6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Tourette's Disorder: new trials by email Literature Review of Tourette's Disorder trials Research Report on Tourette's Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Aripiprazole - Tourette's Disorder, Tic Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 110 | 2013-01-01 | 2015-10-16 |
| Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Aripiprazole, Placebo - Tourette's Disorder, Tic Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 133 | 2012-11-01 | 2015-02-13 |
| Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Aripiprazole - Tourette's Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 170 | 2011-10-19 | 2021-10-07 |
| Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD) Aripiprazole, Placebo - Tourette's Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 83 | 2011-08-02 | 2021-10-07 |
| Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Aripiprazole, Placebo - Tourette's Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 135 | 2011-07-27 | 2021-10-07 |
| Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder aripiprazole, placebo - Chronic Motor or Vocal Tic Disorder, Tourette's Disorder | Phase 3 | Completed | Korea Otsuka Pharmaceutical Co., Ltd. | 61 | 2008-10-01 | 2013-07-26 |
Tic Disorders (6) · Tourette Syndrome (6) · Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Mental Disorders (2) · Movement Disorders (2) · Tics (2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Genetic Diseases, Inborn (6) · Heredodegenerative Disorders, Nervous System (6) · Nervous System Diseases (6) · Neurodegenerative Diseases (6) · Neurodevelopmental Disorders (6) · Basal Ganglia Diseases (4) · Brain Diseases (4) · Central Nervous System Diseases (4) · Mental Disorders (4) · Movement Disorders (4) · Dyskinesias (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2)
Aripiprazole (6)
Otsuka Pharmaceutical Development & Commercialization, Inc. (5) · Korea Otsuka Pharmaceutical Co., Ltd. (1)
United States (5) · Canada (4) · Hungary (4) · Germany (3) · Mexico (3) · Romania (3) · South Korea (3) · Bulgaria (2) · Italy (2) · Taiwan (2) · Ukraine (2) · Spain (1) · Sweden (1)
Eva Kohegyi, MD (5) · Soochurl Cho, MD. Ph.D (1)